OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
35
Results
Show all
Save search
Copy query
Show results for
Unknown
(35)
Publication Date
Release Date
2023
(6)
2022
(6)
2020
(5)
2025
(4)
2014
(4)
2021
(3)
2019
(3)
2024
(2)
2018
(1)
2017
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range.
Not available
S-EPMC7708297
|
biostudies-literature
Cite
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
Not available
S-EPMC6904807
|
biostudies-literature
Cite
Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
Not available
S-EPMC6448454
|
biostudies-literature
Cite
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.
Not available
S-EPMC9922343
|
biostudies-literature
Cite
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial.
Not available
S-EPMC8356211
|
biostudies-literature
Cite
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem.
Not available
S-EPMC9714015
|
biostudies-literature
Cite
Clinical and microbiological outcomes, by causative pathogen, in the ASPECT-NP randomized, controlled, Phase 3 trial comparing ceftolozane/tazobactam and meropenem for treatment of hospital-acquired/ventilator-associated bacterial pneumonia.
Not available
S-EPMC9432134
|
biostudies-literature
Cite
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Not available
S-EPMC10408259
|
biostudies-literature
Cite
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.
Not available
S-EPMC7200056
|
biostudies-literature
Cite
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.
Not available
S-EPMC7121761
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets